| Name | Title | Contact Details |
|---|
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
Outcomes4Me has developed an Artificial Intelligence (AI)-powered patient empowerment platform for shared decision-making between patients and providers. The platform harnesses regulatory-grade, real-world data and patient experiences to generate deeper insights that improve care, accelerate research and achieve better outcomes.
Open Door Health Center is a Homestead, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Salient Surgical Technologies, Inc. is a Portsmouth, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Opioids could kill nearly 500,000 Americans in the next decade. But we can solve this epidemic together.